Cambrium
cambrium.bio
Biotechnology
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$8.6M
3 rounds on record
Latest round
$8.6M
Seed · Oct 2023 · 2 yr ago
Team
11-50
employees, estimated range
Grants
$729k
2 grants · CORDIS
Backers
4
Merantix, Earth Venture Capital
The money's age
Long since its last round
35 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 15, 2025
Won a grant $549k · CORDIS
Oct 30, 2023
Raised a round Seed $8.6M
Apr 1, 2021
Won a grant $180k · CORDIS
Aug 18, 2020
Founded per the company register
Tractionpublic signals, read monthly
Web presence
top 9%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Nov 2025 | $549k | — | CORDIS |
| Seed | Oct 2023 | $8.6M | — | medindia.net |
| Grant | Apr 2021 | $180k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | Cambrium GmbH | de_site |
| Registered | 18 Aug 2020 |
Backed byfrom the funds' portfolios and accelerator catalogs
Merantix 
Earth Venture Capital 
Merantix Capital 
Redstone Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
M3TRIQ designs proteins and discovers molecules with agentic AI. Work with our team, or run design & discovery yourself in the M3TRIQ…
BioGeometry is a digital biology pioneer that specializes in applying generative AI to protein design.
Our breakthrough protein design platform transforms our clients’ visions into reality.
CuspAI builds generative models that search for new materials with target properties. Its first applications focus on carbon capture…
Menten AI designs peptide therapeutics using computational protein design combined with quantum and classical optimisation. Founded in 2018…
Accipiter Biosciences designs de novo, multifunctional protein biologics to treat complex diseases through advanced computational protein…
Overview
Cambrium is a Berlin biotechnology company founded in 2020 that designs proteins as engineering materials. Its computational platform specifies molecules with target properties which are then produced by fermentation, starting with collagen for cosmetics. The company positions protein design as software rather than laboratory trial and error.
News
Cambrium aims to one-up nature with designer proteins that scale sustainably
Nature has done a hell of a job over the last few billion years, but there's always room for improvement. The proteins in our bodies are great but not
Read more
Report
Cambrium Secures €8 Million in Seed Funding to Commercialize New Class of Performance Molecules
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Berlin
Germany
HQ
10-50 est. staff